SCHEMBL3164549

SCHEMBL3164549

CC(=O)NCCNc1cc(NC(=O)CN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 4/20 0.54
▸ HTT P42858 3/20 0.54
▸ RECQL P46063 2/20 0.54
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ CYP2D6 P10635 2/20 0.50
▸ CYP2C9 P11712 2/20 0.50
▸ CYP2C19 P33261 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ CYP2J2 P51589 2/20 0.41
▸ KCNH2 Q12809 1/20 0.40
▸ HRH1 P35367 3/20 0.40
▸ ADORA1 P30542 3/20 0.39
▸ ADORA3 P0DMS8 2/20 0.39
▸ ADORA2A P29274 2/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3161449 0.86 DRD4 (0.49) MEN1KMT2AALDH1A1ADORA1ADORA3
SCHEMBL3172018 0.86 MEN1 (0.42) MEN1KMT2AALDH1A1KCNH2ADORA1
SCHEMBL3164858 0.85 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2ADORA1ADORA2A
SCHEMBL3164709 0.85 NPC1 (0.47) NPSR1MEN1KMT2AALDH1A1ADORA1
SCHEMBL3163125 0.85 NPC1 (0.47) NPSR1MEN1KMT2AALDH1A1ADORA1
SCHEMBL3171949 0.84 PARP1 (0.47) MEN1KMT2AALDH1A1ADORA1ADORA3
SCHEMBL3163330 0.84 NPSR1 (0.48) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL3171920 0.84 ADORA1 (0.47) ALDH1A1ADORA1ADORA3ADORA2AADORA2B
SCHEMBL3175802 0.84 CYP1A2 (0.41) MEN1KMT2ACYP2D6CYP2C19ADORA1
SCHEMBL3163144 0.83 ADORA3 (0.46) MEN1KMT2AALDH1A1SMN1; SMN2ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback